Cocrystal Pharma Inc. (COCP)
NASDAQ: COCP
· Real-Time Price · USD
1.55
0.09 (6.16%)
At close: Jun 17, 2025, 3:59 PM
1.50
-3.23%
Pre-market: Jun 18, 2025, 08:12 AM EDT
6.16% (1D)
| Bid | 1.37 |
| Market Cap | 15.77M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -15.85M |
| EPS (ttm) | -1.56 |
| PE Ratio (ttm) | -0.99 |
| Forward PE | -1.05 |
| Analyst | Buy |
| Ask | 1.63 |
| Volume | 14,591 |
| Avg. Volume (20D) | 19,906 |
| Open | 1.50 |
| Previous Close | 1.46 |
| Day's Range | 1.50 - 1.62 |
| 52-Week Range | 1.12 - 3.26 |
| Beta | 2.12 |
About COCP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol COCP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for COCP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+9.09%
Cocrystal Pharma shares are trading higher after t...
Unlock content with
Pro Subscription
5 months ago
+6.64%
Cocrystal Pharma shares are trading higher after the company announced Phase 1 results for its oral broad-acting antiviral drug CDI-988.
